Listed

Petmed Express Inc: Form 10-Q for the period ended Sep 30, 2019

Filed with the SEC on Oct 30, 2019 and accepted by EDGAR at Oct 30, 2019, 17:15 ET.

Share

Management's discussion and analysis

As filed, 24,022 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Executive Summary

PetMed Express was incorporated in the state of Florida in January 1996. The Company’s common stock is traded on the NASDAQ Global Select Market under the symbol “PETS.” The Company began selling pet medications and other pet health products in September 1996. In March 2010, the Company started offering for sale additional pet supplies on its website, and these items are drop shipped to customers by third party vendors. Presently, the Company’s product line includes approximately 2,500 SKUs of the most popular pet medications, health products, and supplies for dogs, cats, and horses.

The Company markets its products through national advertising campaigns which aim to increase the recognition of the “1-800-PetMeds” brand name, and “PetMeds” family of trademarks, increase traffic on its website at www.1800petmeds.com (http://www.1800petmeds.com), acquire new customers, and maximize repeat purchases. Approximately 84% of all sales were generated via the Internet for the quarter ended September 30, 2019, compared to 85% for the quarter ended September 30, 2018. The Company’s sales consist of products sold mainly to retail consumers. The three-month average purchase was approximately $85 and $87 per order for the quarters ended September 30, 2019 and 2018, respectively, and the six-month average purchase was approximately $86 and $89 per order for the six months ended September 30, 2019 and 2018, respectively.

Critical Accounting Policies

Our discussion and analysis of our financial condition and the results of our operations contained herein are based upon our Condensed Consolidated Financial Statements and the data used to prepare them. The Company’s Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America. On an ongoing basis we re-evaluate our judgments and estimates including those related to product returns, bad debts, inventories, and income taxes. We base our estimates and judgments on our historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. Actual results may differ from these estimates under different assumptions or conditions. Our estimates are guided by observing the following critical accounting policies.

Revenue recognition

The Company generates revenue by selling pet medication products and pet supplies mainly to retail customers. Certain pet supplies offered on the Company’s website are drop shipped to customers. The Company considers itself the principal in the arrangement because the Company controls the specified good before it is transferred to the customer. Revenue contracts contain one performance obligation, which is delivery of the product; customer care and support is deemed not to be a material right to the contract. The transaction price is adjusted at the date of sale for any applicable sales discounts and an estimate of product returns, which are estimated based on historical patterns, however it is not considered a key judgment. There are no amounts excluded from variable consideration. Revenue is recognized when control transfers to the customer at the point in time in which shipment of the product occurs. This key judgment is determined as the shipping point represents the point in time in which the Company has a present right to payment, title has transferred to the customer, and the customer has assumed the risks and rewards of ownership.

Outbound shipping and handling fees are an accounting policy election, and are included in sales as the Company considers itself the principal in the arrangement given responsibility for supplier selection and discretion over pricing. Shipping costs associated with outbound freight after control over a product has transferred to a customer are an accounting policy election and are accounted for as fulfillment costs and are included in cost of sales. The majority of the Company’s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales.

The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers’ inability to make required payments, arising from either credit card charge-backs or insufficient funds checks. The Company determines its estimates of the un-collectibility of accounts receivable by analyzing historical bad debts and current economic trends. The allowance for doubtful accounts was approximately $22,000 at September 30, 2019 compared to $39,000 at March 31, 2019.

Valuation of inventory

Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or market value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence. The inventory reserve was approximately $48,000 at September 30, 2019 compared to $54,000 at March 31, 2019.

Advertising

The Company's advertising expense consists primarily of Internet marketing, direct mail/print, and television advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed when the related brochures and postcards are produced, distributed, or superseded. Television advertising costs are expensed as the advertisements are televised.

Accounting for income taxes

The Company accounts for income taxes under the provisions of ASC Topic 740 (“Accounting for Income Taxes”), which generally requires recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the Company’s Condensed Consolidated Financial Statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities, and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.

Results of Operations

The following should be read in conjunction with the Company’s Condensed Consolidated Financial Statements and the related notes thereto included elsewhere herein. The following table sets forth, as a percentage of sales, certain operating data appearing in the Company’s Condensed Consolidated Statements of Comprehensive Income:

Three Months Ended September 30, 2019 2018 Six Months Ended September 30, 2019 2018
Sales 100.0% 100.0% 100.0% 100.0%
Cost of sales 71.4 64.6 72.1 65.2
Gross profit 28.6 35.4 27.9 34.8
Operating expenses:
General and administrative 9.0 8.7 8.5 8.3
Advertising 6.8 7.4 8.9 7.6
Depreciation 0.8 0.8 0.8 0.7
Total operating expenses 16.6 16.9 18.2 16.6
Income from operations 12.0 18.5 9.7 18.2
Total other income 1.1 1.0 1.1 0.9
Income before provision for income taxes 13.1 19.5 10.8 19.1
Provision for income taxes 3.5 4.4 2.7 4.4
Net income 9.6% 15.1% 8.1% 14.7%

11

Three Months Ended September 30, 2019 Compared With Three Months Ended September 30, 2018, and Six Months Ended September 30, 2019 Compared With Six Months Ended September 30, 2018

Sales

Sales decreased by approximately $1.5 million, or 2.0%, to approximately $69.9 million for the quarter ended September 30, 2019, from approximately $71.4 million for the quarter ended September 30, 2018. For the six months ended September 30, 2019, sales decreased by approximately $8.9 million, or 5.6%, to approximately $149.9 million compared to $158.8 million for the six months ended September 30, 2018. The decrease in sales for the quarter ended September 30, 2019 was primarily due to decreased new order sales offset by increased reorder sales, and the decrease in sales for the six months ended September 30, 2019 was primarily due to decreased new order and reorder sales. The Company acquired approximately 98,000 new customers for the quarter ended September 30, 2019, compared to approximately 117,000 new customers for the same period the prior year. For the six months ended September 30, 2019 the Company acquired approximately 238,000 new customers, compared to 286,000 new customers for the six months ended September 30, 2018. The following chart illustrates sales by various sales classifications:

Three Months Ended September 30,

Sales (In thousands) 2019% 2018% $ Variance % Variance
Reorder Sales $61,851 88.4% $60,979 85.4% $872 1.4%
New Order Sales 8,085 11.6% 10,417 14.6% (2,332) -22.4%
Total Net Sales $69,936 100.0% $71,396 100.0% $(1,460) -2.0%
Internet Sales $58,453 83.6% $60,306 84.5% $(1,853) -3.1%
Contact Center Sales 11,483 16.4% 11,090 15.5% 393 3.5%
Total Net Sales $69,936 100.0% $71,396 100.0% $(1,460) -2.0%

Six Months Ended September 30,

Sales (In thousands) 2019% 2018% $ Variance % Variance
Reorder Sales $129,593 86.4% $132,493 83.4% $(2,900) -2.2%
New Order Sales 20,331 13.6% 26,293 16.6% (5,962) -22.7%
Total Net Sales $149,924 100.0% $158,786 100.0% $(8,862) -5.6%
Internet Sales $125,476 83.7% $134,625 84.8% $(9,149) -6.8%
Contact Center Sales 24,448 16.3% 24,161 15.2% 287 1.2%
Total Net Sales $149,924 100.0% $158,786 100.0% $(8,862) -5.6%

Going forward sales may be adversely affected due to increased competition and consumers giving more consideration to price. No guarantees can be made that sales will grow in the future. The majority of our product sales are affected by the seasons, due to the seasonality of mainly heartworm, and flea and tick medications. For the quarters ended June 30, September 30, December 31, and March 31 of Fiscal 2019, the Company’s sales were approximately 31%, 25%, 21%, and 23%, respectively.

Cost of sales

Cost of sales increased by approximately $3.8 million, or 8.2%, to approximately $49.9 million for the quarter ended September 30, 2019, from approximately $46.1 million for the quarter ended September 30, 2018. For the six months ended September 30, 2019, cost of sales increased by approximately $4.5 million, or 4.3%, to approximately $108.1 million compared to $103.6 million for the same period in the prior year. As a percentage of sales, cost of sales was 71.4% and 64.6% for the quarters ended September 30, 2019 and 2018, respectively, and for the six months ended September 30, 2019 and 2018 cost of sales was 72.1% and 65.2%, respectively. The cost of sales increases can be attributed to price reductions given to customers to stimulate sales in response to increased online competition, and an increase to product costs during the quarter and six months. One of our long-term strategic initiatives and primary purchasing goals has always been to have direct purchasing relationships with the major manufacturers. We now have direct relationships with all major manufacturers which may help lower inventory costs in the future.

Gross profit

Gross profit decreased by approximately $5.3 million, or 20.8%, to approximately $20.0 million for the quarter ended September 30, 2019, from approximately $25.3 million for the quarter ended September 30, 2018. For the six months ended September 30, 2019 gross profit decreased by approximately $13.3 million, or 24.2%, to approximately $41.9 million, compared to $55.2 million for the same period in the prior year. The decrease in gross profit is directly related to a decrease in sales and price reductions during the quarter and six months ended September 30, 2019. Gross profit as a percentage of sales was 28.6% and 35.4% for the three months ended September 30, 2019 and 2018, respectively, and for the six months ended September 30, 2019 and 2018, gross profit as a percentage of sales was 27.9% and 34.8%, respectively. The gross profit percentage decrease can be mainly attributed to price reductions given to customers to stimulate sales in response to increased online competition, and an increase in product costs during the quarter and six months. We now have direct relationships with all major manufacturers and these manufacturers have minimum advertised price policies which allow a general price discipline in the online market, which may help improve our gross margins in the future.

General and administrative expenses

General and administrative expenses increased by approximately $103,000, or 1.7%, to approximately $6.3 million for the quarter ended September 30, 2019, from approximately $6.2 million for the quarter ended September 30, 2018. The increase in general and administrative expenses for the quarter ended September 30, 2019 was primarily due to the following: an $82,000 increase in professional fees related to the annual proxy solicitation, a $51,000 increase in property expenses, a $22,000 increase in bad debt expense, and a $14,000 net increase of other expenses which includes insurance and telephone expenses, offset by a $66,000 decrease in payroll expense related to stock compensation expenses. For the six months ended September 30, 2019, general and administrative expenses decreased by approximately $323,000, or 2.5%, to approximately $12.8 million, compared to $13.1 million for the same period the prior year. The decrease in general and administrative expenses for the six months ended September 30, 2019 was primarily due to the following: a $309,000 decrease in payroll expenses related to a decrease in stock compensation expenses; a $129,000 decrease in bank service fees which was related to decreased sales in the period; and a $21,000 net decrease in other expenses, which included professional fees and license expenses. Offsetting the decrease was a $105,000 increase in property expenses; and a $31,000 net increase in other expenses, which included bad debt and insurance expenses.

Advertising expenses

Advertising expenses decreased by approximately $544,000, or 10.3%, to approximately $4.8 million for the quarter ended September 30, 2019, from approximately $5.3 million for the quarter ended September 30, 2018. For the six months ended September 30, 2019, advertising expenses increased by approximately $1.4 million, or 11.4%, to approximately $13.4 million compared to advertising expenses of approximately $12.0 million for the six months ended September 30, 2018. The decrease in advertising expenses for the three months ended September 30, 2019 was due to the elimination of television advertising in the quarter. The increase in advertising expenses for the six months ended September 30, 2019 was related to the re-addition of television advertising in the quarter ended June 30, 2019. The advertising costs of acquiring a new customer, defined as total advertising costs divided by new customers acquired, was $49 for the quarter ended September 30, 2019 compared to $45 for the quarter ended September 30, 2018, and $56 for the six months ended September 30, 2019 compared to $42 for the six months ended September 30, 2018. Advertising cost of acquiring a new customer can be impacted by the advertising environment, the effectiveness of our advertising creative, advertising spending, and price competition. Historically, the advertising environment fluctuates due to supply and demand. A more favorable advertising environment may positively impact future new order sales, whereas a less favorable advertising environment may negatively impact future new order sales.

As a percentage of sales, advertising expense was 6.8% and 7.4% for the quarters ended September 30, 2019 and 2018, respectively, and for the six months ended September 30, 2019 and 2018 advertising expense was 8.9% and 7.6%, respectively. The decrease in advertising expense as a percentage of total sales for the quarter ended September 30, 2019 can be mainly attributed to the elimination of television advertising in the September quarter. The increase in advertising expense as a percentage of total sales for the six months ended September 30, 2019 can be mainly attributed to the re-addition of television advertising in the June quarter to stimulate sales and promote brand awareness. The Company currently anticipates advertising as a percentage of sales to be approximately 9.0% for fiscal 2020. However, the advertising percentage will fluctuate quarter to quarter due to seasonality and advertising availability.

Depreciation

Depreciation expense increased by approximately $20,000 to approximately $572,000 for the quarter ended September 30, 2019, from approximately $552,000 for the quarter ended September 30, 2018. For both the six months ended September 30, 2019 and 2018 depreciation expense was approximately $1.1 million. The increase to depreciation expense for the quarter and six months ended September 30, 2019 can be attributed to new property and equipment additions during the same periods.

Other income

Other income increased by approximately $80,000 to approximately $763,000 for the quarter ended September 30, 2019 from approximately $683,000 for the quarter ended September 30, 2018. For the six months ended September 30, 2019 other income increased by approximately $208,000 to approximately $1.6 million compared to approximately $1.4 million for the same period in the prior year. The increase to other income for the quarter and six months ended September 30, 2019 is primarily related to increased interest income due to increased interest rates. Interest income may decrease in the future as the Company utilizes its cash balances on its share repurchase plan, with approximately $28.7 million remaining as of September 30, 2019, on any quarterly dividend payment, on its operating activities, or with a decrease in interest rates.

Provision for income taxes

For the quarters ended September 30, 2019 and 2018, the Company recorded an income tax provision of approximately $2.5 million and $3.1 million, respectively, and for the six months ended September 30, 2019 and 2018, the Company recorded an income tax provision of approximately $4.1 million and $7.0 million, respectively. The decrease in the income tax provision for the quarter and six months ended September 30, 2019 is related to a decrease in operating income during the period. The effective tax rate for the quarter ended September 30, 2019 was approximately 27.0%, compared to 22.6% for the quarter ended September 30, 2018, and the effective tax rate for the six months ended September 30, 2019 was approximately 25.5% compared to 23.1% for the six months ended September 30, 2018. The increase to the effective rate for the three and six months ended September 30, 2019 can be attributed to a $322,000 income tax charge related to restricted stock compensation, compared to a $134,000 income tax benefit related to restricted stock compensation, which was recognized in the quarter ended September 30, 2018.

Liquidity and Capital Resources

The Company’s working capital at September 30, 2019 and March 31, 2019 was $99.7 million and $107.8 million, respectively. The $8.1 million decrease in working capital was primarily attributable to the share buyback and dividends paid in the period. Net cash provided by operating activities was $17.3 million and $20.4 million for the six months ended September 30, 2019 and 2018, respectively. This decrease is mainly attributed to a decrease in net income offset by a decrease in inventory for the six months ended September 30, 2019, compared to an increase in inventory for six months ended September 30, 2018. Net cash used in investing activities was $416,000 for the six months ended September 30, 2019, compared to net cash used in investing activities of $450,000 for the six months ended September 30, 2019. This change in investing activities is related to property and equipment additions in the six months ended September 30, 2019. Net cash used in financing activities was $22.5 million for the six months ended September 30, 2019, compared to $10.8 million for the same period in the prior year. The increase to financing activities relates to the Company purchasing approximately 613,000 shares of its common stock for approximately $11.5 million during the period and the remaining increase to financing activities related to an increase in the dividend paid in the six months ended September 30, 2019.

At September 30, 2019, the Company had approximately $28.7 million remaining under the Company’s share repurchase plan. Subsequent to September 30, 2019, on October 21, 2019 our Board of Directors declared a $0.27 per share dividend. The Board established a November 4, 2019 record date and a November 15, 2019 payment date. Depending on future market conditions the Company may utilize its cash and cash equivalents on the remaining balance of its current share repurchase plan, on dividends, or on its operating activities.

At September 30, 2019, the Company had no material outstanding lease commitments. See Note 1, Recent Accounting Pronouncements, to the Condensed Consolidated Financial Statements within this Form 10-Q for the Company’s disclosure related to leases. We are not currently bound by any long or short term agreements for the purchase or lease of capital expenditures. Any material amounts expended for capital expenditures would be the result of an increase in the capacity needed to adequately provide for any increase in our business. To date we have paid for any needed additions to our capital equipment infrastructure from working capital funds and anticipate this being the case in the future.

Presently, we have approximately $4.6 million forecasted for capital expenditures for the remainder of fiscal 2020, the majority of which will be invested in our e-commerce platform to better service our customers, which will be funded through cash from operations. The Company’s primary source of working capital is cash from operations. The Company presently has no need for alternative sources of working capital, and has no commitments or plans to obtain additional capital.

Off-Balance Sheet Arrangements

The Company had no off-balance sheet arrangements at September 30, 2019.

Cautionary Statement Regarding Forward-Looking Information

Certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify these forward-looking statements by the words "believes," "intends," "expects," "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," "predicts," "estimates," "anticipates," or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions. Actual future results may differ significantly from the results discussed in the forward-looking statements. A reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements, which apply only as of the date of this quarterly report. When used in this quarterly report on Form 10-Q, "PetMed Express," "1-800-PetMeds," "PetMeds," "PetMed," "PetMeds.com," “1800PetMeds.com,” "PetMed.com," "PetMed Express.com," "the Company," "we," "our," and "us" refers to PetMed Express, Inc. and our subsidiaries.

Market risk

As filed, 1,557 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Market risk generally represents the risk that losses may occur in the value of financial instruments as a result of movements in interest rates, foreign currency exchange rates, and commodity prices. Our financial instruments include cash and cash equivalents, accounts receivable, and accounts payable. The book values of cash equivalents, accounts receivable, and accounts payable are considered to be representative of fair value because of the short maturity of these instruments. Interest rates affect our return on excess cash and investments. At September 30, 2019, we had $94.9 million in cash and cash equivalents, and the majority of our cash and cash equivalents generate interest income based on prevailing interest rates. A significant change in interest rates would impact the amount of interest income generated from our excess cash and cash equivalents. It would also impact the market value of our cash and cash equivalents. Our cash equivalents are subject to market risk, primarily interest rate and credit risk. Our cash equivalents are managed by a limited number of outside professional managers within investment guidelines set by our Board of Directors. Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by restricting our cash and cash equivalents to high-quality debt instruments with both short and long term maturities. We do not hold any derivative financial instruments that could expose us to significant market risk. At September 30, 2019, we had no debt obligations.

Controls and procedures

As filed, 1,470 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The Company’s management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 promulgated under the Securities Exchange Act of 1934, as amended) as of the quarter ended September 30, 2019, the end of the period covered by this report (the "Evaluation Date"). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective such that the information relating to our Company, including our consolidated subsidiaries, required to be disclosed by the Company in reports that it files or submits under the Exchange Act: (1) is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 386 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition, results of operations, and trading price of our common stock. Please refer to our Annual Report on Form 10-K for Fiscal Year 2019 for additional information concerning these and other uncertainties that could negatively impact the Company.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue6 months2019-04-01 to 2019-09-30$149.9mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2019-07-01 to 2019-09-30$49.9mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-04-01 to 2019-09-30$108.1mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-07-01 to 2019-09-30$20.0mus-gaap:GrossProfit
Gross profit6 months2019-04-01 to 2019-09-30$41.9mus-gaap:GrossProfit
Operating income3 months2019-07-01 to 2019-09-30$8.4mus-gaap:OperatingIncomeLoss
Operating income6 months2019-04-01 to 2019-09-30$14.5mus-gaap:OperatingIncomeLoss
Income tax3 months2019-07-01 to 2019-09-30$2.5mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-04-01 to 2019-09-30$4.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-07-01 to 2019-09-30$6.7mus-gaap:NetIncomeLoss
Net income6 months2019-04-01 to 2019-09-30$12.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-07-01 to 2019-09-30$0.33us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-04-01 to 2019-09-30$0.60us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-07-01 to 2019-09-30$0.33us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-04-01 to 2019-09-30$0.60us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-07-01 to 2019-09-3019,973,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-04-01 to 2019-09-3020,109,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-04-01 to 2019-09-30$17.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-04-01 to 2019-09-30$416.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2019-04-01 to 2019-09-30$11.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2019-04-01 to 2019-09-30$11.5mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-09-30$94.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-30$118.3mus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$145.5mus-gaap:Assets
Current liabilitiesAt period end2019-09-30$18.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-30$19.9mus-gaap:Liabilities
Shareholders' equityAt period end2019-09-30$125.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-19-020948. Last ingested by Listed: Nov 13, 2026, 14:26 ET. Listed shows no prices and gives no investment advice.